摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5-bromopentyl)dimethylsilane | 114569-15-2

中文名称
——
中文别名
——
英文名称
(5-bromopentyl)dimethylsilane
英文别名
(5-Bromopentyl)(dimethyl)silane;5-bromopentyl(dimethyl)silane
(5-bromopentyl)dimethylsilane化学式
CAS
114569-15-2
化学式
C7H17BrSi
mdl
——
分子量
209.201
InChiKey
IPOBRYLWNHNVPQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.04
  • 重原子数:
    9
  • 可旋转键数:
    5
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

反应信息

  • 作为反应物:
    描述:
    (5-bromopentyl)dimethylsilane 在 dihydrogen hexachloroplatinate 作用下, 以 乙醇异丙醇甲苯 为溶剂, 反应 49.0h, 生成 (5-(dimethyl(3-(1,8-naphthalimido)propyl)-silyl)pentyl)dimethyl(3-phthalimidopropyl)ammonium bromide
    参考文献:
    名称:
    Synthesis and pharmacological characterization of new silicon-based W84-type allosteric modulators for ligand binding to muscarinic M2 receptors
    摘要:
    The silicon-based allosteric modulators of ligand binding to muscarinic acetylcholine receptors [R-1-(CH2)(3)-SiMe2-(CH2)(5)- NMe2-(CH2)(3)-R-1]Br (3), [R-2-(CH2)(3)-SiMe2 (CH2)(5)-NMe2-(CH2)(3)-R-2]Br (4), [R-1-(CH2)(3)-SiMe2-(CH2)(3)-NMe2-(CH2)(3)- R-2]Br (5), and [R-2-(CH2)(3)-SiMe2- (CH2)(5)-NMe2-(CH2)(3)-R-1]Br (6) (R-1 = phthalimido; R-2 = 1,8-naphthalimido) were sythesized, starting from chlorodimethylsilane. Compounds 3-6 were studied for their allosteric interaction at porcine heart muscarinic M-2 receptors. They inhibited the dissociation of the orthosteric ligand [H-3]N-methylscopolamine ([H-3]NMS) with similar potency; compounds 4 and 6 yielded steep concentration-effect curves. All compounds enhanced [H-3]NMS equilibrium binding, but with different efficacies. The effect of 4 on [H-3]NMS binding was studied at cloned M-1-M-5 receptor subtypes. Compound 4 did not affect [H-3]NMS equilibrium binding at M-1, M-3, M-4, and M-5 receptors, thus representing an M-2-selective allosteric enhancer of [H-3]NMS binding. (C) 2003 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/s0022-328x(03)00553-9
  • 作为产物:
    描述:
    (5-bromopentyl)chlorodimethylsilane 在 lithium aluminium tetrahydride 作用下, 以 乙醚 为溶剂, 反应 0.5h, 以87%的产率得到(5-bromopentyl)dimethylsilane
    参考文献:
    名称:
    Synthesis and pharmacological characterization of new silicon-based W84-type allosteric modulators for ligand binding to muscarinic M2 receptors
    摘要:
    The silicon-based allosteric modulators of ligand binding to muscarinic acetylcholine receptors [R-1-(CH2)(3)-SiMe2-(CH2)(5)- NMe2-(CH2)(3)-R-1]Br (3), [R-2-(CH2)(3)-SiMe2 (CH2)(5)-NMe2-(CH2)(3)-R-2]Br (4), [R-1-(CH2)(3)-SiMe2-(CH2)(3)-NMe2-(CH2)(3)- R-2]Br (5), and [R-2-(CH2)(3)-SiMe2- (CH2)(5)-NMe2-(CH2)(3)-R-1]Br (6) (R-1 = phthalimido; R-2 = 1,8-naphthalimido) were sythesized, starting from chlorodimethylsilane. Compounds 3-6 were studied for their allosteric interaction at porcine heart muscarinic M-2 receptors. They inhibited the dissociation of the orthosteric ligand [H-3]N-methylscopolamine ([H-3]NMS) with similar potency; compounds 4 and 6 yielded steep concentration-effect curves. All compounds enhanced [H-3]NMS equilibrium binding, but with different efficacies. The effect of 4 on [H-3]NMS binding was studied at cloned M-1-M-5 receptor subtypes. Compound 4 did not affect [H-3]NMS equilibrium binding at M-1, M-3, M-4, and M-5 receptors, thus representing an M-2-selective allosteric enhancer of [H-3]NMS binding. (C) 2003 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/s0022-328x(03)00553-9
点击查看最新优质反应信息

文献信息

  • Synthesis and pharmacological characterization of new silicon-based W84-type allosteric modulators for ligand binding to muscarinic M2 receptors
    作者:Seraina Duda-Johner、Jürgen O Daiß、Klaus Mohr、Reinhold Tacke
    DOI:10.1016/s0022-328x(03)00553-9
    日期:2003.11
    The silicon-based allosteric modulators of ligand binding to muscarinic acetylcholine receptors [R-1-(CH2)(3)-SiMe2-(CH2)(5)- NMe2-(CH2)(3)-R-1]Br (3), [R-2-(CH2)(3)-SiMe2 (CH2)(5)-NMe2-(CH2)(3)-R-2]Br (4), [R-1-(CH2)(3)-SiMe2-(CH2)(3)-NMe2-(CH2)(3)- R-2]Br (5), and [R-2-(CH2)(3)-SiMe2- (CH2)(5)-NMe2-(CH2)(3)-R-1]Br (6) (R-1 = phthalimido; R-2 = 1,8-naphthalimido) were sythesized, starting from chlorodimethylsilane. Compounds 3-6 were studied for their allosteric interaction at porcine heart muscarinic M-2 receptors. They inhibited the dissociation of the orthosteric ligand [H-3]N-methylscopolamine ([H-3]NMS) with similar potency; compounds 4 and 6 yielded steep concentration-effect curves. All compounds enhanced [H-3]NMS equilibrium binding, but with different efficacies. The effect of 4 on [H-3]NMS binding was studied at cloned M-1-M-5 receptor subtypes. Compound 4 did not affect [H-3]NMS equilibrium binding at M-1, M-3, M-4, and M-5 receptors, thus representing an M-2-selective allosteric enhancer of [H-3]NMS binding. (C) 2003 Elsevier B.V. All rights reserved.
查看更多